Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from ...

National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained ...

On August 19th, Medtronic released its earnings report for the fiscal first quarter ended July 25th, 2025. The company's ...

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment ...

Medtronic (NYSE:MDT) underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their recent ratings, ...

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase ...

If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the underlying company is healthy and growing, its stock price will likely ...

The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

When Geoff Martha, chairman and CEO of Medtronic, took over the medical device maker’s Restorative Therapies Group in 2015, the company faced a tough decision. The group at the time was ...

The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...

Diabetes business will become an independent publicly traded company, and is expected to add to Medtronic earnings and margins post separation Medtronic PLC announced Wednesday plans to separate its ...